/Companies

Proxima

Founded 2019 · 77 employees on LinkedIn · 4 known investors

Find your way into Proxima

Sign up to see every warm intro you have to Proxima

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Proxima team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Proxima Bio is a biotechnology company that applies artificial intelligence and computational methods across chemistry and biology to develop therapeutics, including work in protein degradation. It operates a drug discovery platform and advances a program referred to as NEO-1.

Founders & leadership

Proxima was founded in 2019 by Jonathan Bernardini, Zachary Carpenter, and Luca Naef.

JBJonathan Bernardini
Jonathan BernardiniFounderJonathan Bernardini is a cell biologist with expertise in antibody drug development. He founded Proxima, a biotech company developing proximity therapeutics through a drug discovery engine and structural proteomics platform.
ZCZachary Carpenter
Zachary CarpenterFounder & CEO
LNLuca Naef
Luca NaefCo-Founder & CTO
ZK
Zachary KanterChief Business Officer
MB
Michael BellChief Financial Officer
JS
Jeremy SokoloveInterim Chief Medical Officer
MB
Michael BronsteinChief Scientist in Residence
DM
Dan MarquessChief Scientific Officer

Investors · 4

Also in the syndicate · 1

NVIDIA NVentures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Proxima went on to found or lead other companies.

In the news

Frequently asked questions

What does Proxima do?
Proxima Bio is a biotechnology company that applies artificial intelligence and computational methods across chemistry and biology to develop therapeutics, including work in protein degradation. It operates a drug discovery platform and advances a program referred to as NEO-1.
Who founded Proxima?
Proxima was founded by Jonathan Bernardini, Zachary Carpenter, Luca Naef in 2019.
Who are Proxima's investors?
Proxima's investors include Magnetic Ventures, Modi Ventures, DCVC (Data Collective).